Maria Victoria Revuelta

15PUBLICATIONS
108CO-AUTHORS
Molecular targetsHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersMechanobiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Sep 18, 2026
BUB1B Mitotic Kinase Dependency Reveals CENP-E Inhibition as a Tractable Approach for Castration and Enzalutamide Resistant Prostate Cancer.

|Jun 09, 2025
Thyroid hormones contribute to JAK/STAT pathway abnormal activation, promoting T-cell lymphoma dissemination.

Mercedes Debernardi, Alejandro Correa, Lucero Alvarado

|Apr 02, 2024
Germinal Center Dark Zone harbors ATR-dependent determinants of T-cell exclusion that are also identified in aggressive lymphoma.

Valeria Cancila, Gaia Morello, Giorgio Bertolazzi

|Oct 06, 2023
XPO1 Enables Adaptive Regulation of mRNA Export Required for Genotoxic Stress Tolerance in Cancer Cells.

Rossella Marullo, Sarah C Rutherford, Maria V Revuelta

|Mar 17, 2023
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma.

Marta Larrayoz, Maria J Garcia-Barchino, Jon Celay

|Feb 27, 2023
The eukaryotic translation initiation factor eIF4E reprograms alternative splicing.

Mehdi Ghram, Gavin Morris, Biljana Culjkovic-Kraljacic

Pageof 3

Frequent Collaborators

11 joint publications

Leandro Cerchietti

4 joint publications

Rossella Marullo

4 joint publications

Nikita Kotlov

3 joint publications

Jude M Phillip